FDAnews
www.fdanews.com/articles/120829-johnson-38-johnson-buys-18-percent-stake-in-crucell

Johnson & Johnson Buys 18 Percent Stake in Crucell

September 28, 2009
U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in Dutch biotechnology company Crucell NV for euro301.8 million ($440 million) in hopes to develop a universal flu vaccine, the companies said.
denverpost